GeneOne Life Science, Inc.

₩2,670As of Sun 8 Nov 2026, 12:00 UTC
KRX:011000Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (20.42%)
Div yield —
ROE (99.68%)
Biotechnology
Beta (5Y) 0.77
PE TTM —
TSR TTM (74.57%)
Mkt cap ₩48.42B
ROIC (32.99%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,542
(4.78%)
369.51%
Hold 7|4|7|3|7
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
65.65
65.35
66.02
68.88
8.45%
10.46%
8.28%
16.42%
Revenue₩B
2.358
2.327
2.294
2.282
4.18%
4.58%
(0.22%)
(3.82%)
Peers (US$35.70M)
Cap (US$)
PE
49.81M
—
33.87M
—
23.93M
—
35.75M
26.42x
Capital
TTM
5Y
10Y
Leveragex
3.315
0.930
0.776
EBIT/Intx
1.844
0.050
0.045
Own earn%
102.90
20.85
25.72
Sh yield%
20.34
20.65
21.65
Owners
Insiders/Inst%
6.01
70.22
Short interest%
4.44
SBC / revenue%
3.71
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
2–13
$1 testx
0.0
Incr. ROIC%
5